Asian Spectator

The Times Real Estate

.

Semaglutide in people with obesity: boosts wellbeing and abili...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BAGSVAERD, Denmark, May 13, 2021 /PRNewswire-AsiaNet/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

‘Negara +62’: Kode telepon global yang kini jadi narasi kritik sosial

Salah satu pekerja yang tengah menggelar aksi demonstrasi pada Oktober 2020 di Bandung, Indonesia, untuk menolak Undang-Undang Cipta Kerja.Algi Febri SugitaIstilah “+62” awalnya dikenal se...

Choosing the Right Wholesale Packaging Supplies for Your Industry in Adelaide

In the bustling business landscape of Adelaide, effective packaging is more than just a container; it's a crucial element of your brand identity, product protection, and overall customer experience...

3 alasan mengapa tes kehamilan pada remaja di sekolah harus dilarang

Ilustrasi tes kehamilan pada remaja.Diego Cervo/ShutterstockAwal tahun 2025, kebijakan salah satu SMA di Cianjur, Jawa Barat, menggemparkan publik karena mewajibkan siswa menjalani tes kehamilan selep...